Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Arzneimittel-Forschung

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 8595088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omeprazole ameliorates aspirin-induced gastroduodenal injury

  2005cited by this paper
• The consequences of H2 receptor antagonist — piroxicam coadministration in patients with joint disorders

  2004cited by this paper
• A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen.

  1994cited by this paper
• Short report: the effect of misoprostol on the anaemia of NSAID enteropathy

  1994cited by this paper
• Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial.

  1994cited by this paper
• Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.

  1994cited by this paper
• [Critical evaluation of economic analysis exemplified by preventive misoprostol administration in antirheumatic drug-induced gastropathy].

  1994cited by this paper
• Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.

  1994cited by this paper
• A review of selected newer nonsteroidal anti-inflammatory drugs.

  1994cited by this paper
• Review article: controversies in NSAID‐induced gastroduodenal damage‐do they matter?

  1994cited by this paper
• An etiologic approach to management of duodenal and gastric ulcers.

  1994cited by this paper
• Efficacy and Tolerability of Nabumetone in the Treatment of Osteoarthritis of the Knee Joint: An Open Trial

  1994cited by this paper
• Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).

  1994cited by this paper
• Antinociceptive effects of non-steroidal anti-inflammatory drugs in a rat model of unilateral hindpaw inflammation.

  1994cited by this paper
• Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat

  1994cited by this paper
• Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat.

  1994cited by this paper
• Nabumetone: a clinical appraisal.

  1994cited by this paper
• Agranulocytosis Associated with Etodolac

  1994cited by this paper
• Intestinal toxicity of non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• A diclofenac derivative without ulcerogenic properties.

  1994cited by this paper
• Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID.

  1994cited by this paper
• A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.

  1993cited by this paper
• Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man.

  1993cited by this paper
• The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol.

  1993cited by this paper
• Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers

  1992cited by this paper
• Acid secretion and the H,K ATPase of stomach.

  1992cited by this paper
• Antiarthritic profile of BF-389 — A novel anti-inflammatory agent with low ulcerogenic liability

  1992cited by this paper
• Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.

  1990cited by this paper
• Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

  1989cited by this paper
• Treatment of NSAID‐induced gastrointestinal lesions with cimetidine: an international multicentre collaborative study

  1988cited by this paper
• Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

  1988cited by this paper
• Epidemiology of NSAID‐induced gastrointestinal problems and the role of cimetidine in their prevention

  1988cited by this paper
• Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

  1988cited by this paper
• The role of H2‐receptor antagonists in the prevention of NSAID‐induced gastrointestinal damage

  1988cited by this paper
• A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.

  1988cited by this paper
• Protection by misoprostol against naproxen-induced gastric mucosal damage.

  1987cited by this paper
• [Effects of enprostil on changes in the gastric transepithelial potential differential induced by aspirin].

  1987cited by this paper
• Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients.

  1987cited by this paper
• Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa.

  1986cited by this paper
• Reduction of Aspirin‐Induced Gastroduodenal Mucosal Damage with Ranitidine

  1986cited by this paper
• Diclofenac sodium in the treatment of rheumatoid arthritis and osteoarthritis.

  1985cited by this paper
• Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man

  1985cited by this paper
• THE GASTRIC ANTISECRETORY ACTIONS OF PROSTAGLANDIN E2 AND STABLE PROSTACYCLIN ANALOGUES AGAINST DIFFERENT SECRETAGOGUES IN PERFUSED WHOLE‐STOMACHS OF RAT OR MOUSE in vitro

  1981cited by this paper
• A quantitative study of metiamide, a histamine H2‐antagonist, on the isolated whole rat stomach.

  1976cited by this paper
• THE EFFECT OF METIAMIDE ON ACID SECRETION STIMULATED BY GASTRIN, ACETYLCHOLINE AND DIBUTYRYL CYCLIC ADENOSINE 3′, 5′‐MONOPHOSPHATE IN THE ISOLATED WHOLE STOMACH OF THE RAT

  1976cited by this paper
• INVESTIGATION OF THE VASODILATOR AND ANTISECRETORY ROLE OF PROSTAGLANDINS IN THE RAT GASTRIC MUCOSA BY USE OF NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS

  1975cited by this paper

• PLATELET AGGREGATION IN A PATIENT IN NEED THEREOF

  2017cites this paper
• [Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis]

  2011cites this paper
• Species difference in the in vitro and in vivo metabolism of amtolmetin guacil

  2010cites this paper
• In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.

  2007cites this paper
• Prodrugs of Carboxylic Acids

  2007cites this paper
• In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.

  2007cites this paper
• Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.

  2005cites this paper
• Morphological Features of Rat Gastric Mucosa after Acute and Chronic Treatment with Amtolmetin Guacyl: Comparison with Non-Selective and COX-2-Selective NSAIDs

  2004cites this paper
• Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.

  2003cites this paper
• Characterization of Mefenamic Acid-Guaiacol Ester: Stability and Transport Across Caco-2 Cell Monolayers

  2002cites this paper
• Protective Effect of Amtolmetin Guacyl versus Placebo Diclofenac and Misoprostol in Healthy Volunteers Evaluated as Gastric Electrical Activity in Alcohol-Induced Stomach Damage

  2001cites this paper
• Anti-inflammatory and Antiplatelet Effects of Amtolmetin Guacyl, a New Gastroprotective Non-steroidal Anti-inflammatory Drug

  2001cites this paper
• The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study

  2001cites this paper
• The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug.

  2000cites this paper
• Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase.

  2000cites this paper
• Amtolmetin Guacyl versus Piroxicam in Patients with Osteoarthritis

  2000cites this paper
• Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.

  1999cites this paper
• Gastric effects of the novel non-steroidal anti-inflammatory drug amtolmetin guacyl.

  1999cites this paper
• Gastrosparing Effect of New Antiinflammatory Drug Amtolmetin Guacyl in the Rat (Involvement of Nitric Oxide)

  1999cites this paper
• A Meta-Analysis of the Tolerability of Amtolmetin Guacil, a Novel, Effective Nonsteroidal Anti-Inflammatory Drug, Compared with Established Agents

  1999cites this paper